Fish skin disease are common microbial infections affecting skin of fishes which lead to physiological issues. Fish skin disease diagnostic assays help in early detection and treatment of fungal, bacterial and viral infections. The global fish skin disease market demand for diagnostic assays is growing due to rising prevalence of fungal and bacterial infections in aquaculture industry. With increasing fish farming practices, risk of diseases transmission is also high requiring regular diagnostics.
The global Fish Skin Disease Market is estimated to be valued at US$ 1.84 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
The increasing prevalence of fish skin diseases is majorly driving the growth of global fish skin disease market during the forecast period. Rising commercial fish farming for food supply has increased the risk of infectious diseases transmission among fishes living in dense populations. According to OIE, bacterial skin ulcers caused by Flexibacter columnaris and Streptococcus iniae remains one of the most prevalent and economically important bacterial diseases affecting several fish species worldwide including salmon, trout and tilapia. As per statistics, losses due to flexibacterial gill disease in farmed salmon range from 5-15% of total production annually. Thus, increasing prevalence of common fish diseases is expected to boost the diagnostics demand over the forecast period.
Segment Analysis
The global fish skin disease market is dominated by the infections segment, which accounted for nearly 30% share of the overall market in 2023. Fish skin infections are common in aquaculture as fish are more susceptible to various bacterial, viral, fungal and parasitic infections due to stress factors such as overcrowding, poor water quality and sanitation. The increasing demand for aquaculture products and rising adoption of intensive culture practices have further accelerated the risk of infections in fish.
Key Takeaways
The Global Fish Skin Disease Market Size is expected to witness high growth over the forecast period. The global fish skin disease market is estimated to be valued at US$ 1.84 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030,.
Regionally, Asia Pacific dominated the global market with more than 35% share in 2023 owing to the large aquaculture production in China and India. Rapid industrialization of fish farming along with the low cost of production and lax implementation of biosecurity measures have fueled the spread of various fish skin diseases in the region.
Key players operating in the fish skin disease market are Glaxo Smith Kline PLC., Isarna Therapeutics GmbH, Aptose Biosciences Inc., Regulus Therapeutics Inc., and Rexahn Pharmaceuticals Inc. Glaxo Smith Kline PLC offers anti-parasitic drugs for treating skin infections in aquaculture, while Isarna Therapeutics GmbH provides RNA-based immunomodulatory therapeutics targeting viral infections in fish. Researchers are also exploring RNA interference and gene-silencing techniques to develop effective treatments against fungal and bacterial pathogens.
Get more insights on this topic:
https://www.marketwebjournal.com/fish-skin-disease-market-market-size-and-share-analysis/
